QSAR and docking studies on Triazole Benzene Sulfonamides with human Carbonic anhydrase IX inhibitory activity

2019 ◽  
Vol 33 (12) ◽  
Author(s):  
P. Gopinath ◽  
M.K. Kathiravan
2019 ◽  
Vol 20 (5) ◽  
pp. 1208 ◽  
Author(s):  
Kerem Buran ◽  
Silvia Bua ◽  
Giulio Poli ◽  
F. Önen Bayram ◽  
Tiziano Tuccinardi ◽  
...  

A novel series of 8-substituted coumarin-based compounds, characterized by the presence of alkylpiperazine and arylpiperazine chains, were synthesized and tested for their inhibitory activity against four human carbonic anhydrase (hCA) isoforms. All compounds displayed nanomolar potency against the cancer-related hCA IX and hCA XII; moreover, they were shown to be devoid of any inhibitory activity toward the cytosolic hCA I and hCA II up to 10 µM concentration in the assay system. Therefore, the synthesized coumarin ligands demonstrated to be potent and selective hCA IX/XII inhibitors, and were shown to be as potent as the reference inhibitor acetazolamide against hCA XII, with single-digit nanomolar Ki values. Molecular modeling studies provided a rationale for explaining the selectivity profile of these non-classic hCA inhibitors and their interactions with the enzymes, according to their specific mechanism of action, thus paving the way for future structure-based lead optimization studies.


RSC Advances ◽  
2021 ◽  
Vol 11 (60) ◽  
pp. 38079-38093
Author(s):  
Gopinath P. ◽  
Kathiravan M. K.

Compound 27 as best theoritical lead interacting with the residues of hCA IX enzyme.


2021 ◽  
Vol 14 (7) ◽  
pp. 693
Author(s):  
Kalyan K. Sethi ◽  
KM Abha Mishra ◽  
Saurabh M. Verma ◽  
Daniela Vullo ◽  
Fabrizio Carta ◽  
...  

New derivatives were synthesised by reaction of amino-containing aromatic sulphonamides with mono-, bi-, and tricyclic anhydrides. These sulphonamides were investigated as human carbonic anhydrases (hCAs, EC 4.2.1.1) I, II, IX, and XII inhibitors. hCA I was inhibited with inhibition constants (Kis) ranging from 49 to >10,000 nM. The physiologically dominant hCA II was significantly inhibited by most of the sulphonamide with the Kis ranging between 2.4 and 4515 nM. hCA IX and hCA XII were inhibited by these sulphonamides in the range of 9.7 to 7766 nM and 14 to 316 nM, respectively. The structure–activity relationships (SAR) are rationalised with the help of molecular docking studies.


2022 ◽  
Author(s):  
Anne E. G. Lenferink ◽  
Jason Baardsnes ◽  
Traian Sulea ◽  
Cunle Wu ◽  
Maurizio Acchione ◽  
...  

2018 ◽  
Vol 157 ◽  
pp. 1214-1222 ◽  
Author(s):  
Andrea Angeli ◽  
Elena Trallori ◽  
Marta Ferraroni ◽  
Lorenzo Di Cesare Mannelli ◽  
Carla Ghelardini ◽  
...  

2018 ◽  
Vol 33 (1) ◽  
pp. 1299-1308 ◽  
Author(s):  
Özlen Güzel-Akdemir ◽  
Andrea Angeli ◽  
Kübra Demir ◽  
Claudiu T. Supuran ◽  
Atilla Akdemir

Sign in / Sign up

Export Citation Format

Share Document